Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

1. Ugarte, A.
2. Gil-Bea, F.
3. García-Barroso, C.
4. Cedazo-Minguez, A.
5. Ramírez, M.J.
6. Franco, R.
7. García-Osta, A.
8. Oyarzabal, J.
9. Cuadrado-Tejedor, M.